Cargando…

Assessment of Genetic Aspects of Non-alcoholic Fatty Liver and Premature Cardiovascular Events

Recent evidence has demonstrated a strong interplay and multifaceted relationship between non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD). CVD is the major cause of death in patients with NAFLD. NAFLD also has strong associations with diabetes and metabolic syndrome. In th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saki, Sara, Saki, Nader, Poustchi, Hossein, Malekzadeh, Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iranian Association of Gastroerterology and Hepatology 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320986/ https://www.ncbi.nlm.nih.gov/pubmed/32626560 http://dx.doi.org/10.34172/mejdd.2020.166

Ejemplares similares

Fibroscan for assessing liver fibrosis: An acceptable alternative for liver biopsy: Fibroscan: an acceptable alternative for liver biopsy
por: Malekzadeh, Reza, et al.
Publicado: (2011)

Prevalence of Non-Alcoholic Fatty Liver Disease and Its Predictors in North of Iran
por: AMIRKALALI, Bahareh, et al.
Publicado: (2014)

The Circulating CTRP13 in Type 2 Diabetes and Non-Alcoholic Fatty Liver Patients
por: Shanaki, Mehrnoosh, et al.
Publicado: (2016)

Malnutrition in Liver Cirrhosis:The Influence of Protein and Sodium
por: Eghtesad, Sareh, et al.
Publicado: (2013)

Egg consumption and risk of non-alcoholic fatty liver disease
por: Mokhtari, Zeinab, et al.
Publicado: (2017)

The Prevalence of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus in an Iranian Population
por: Rabiee, Behnam, et al.
Publicado: (2017)

Non-alcoholic fatty liver disease is not independent risk factor for cardiovascular disease event: A cohort study
por: Motamed, Nima, et al.
Publicado: (2020)

Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
por: Fadaei, Reza, et al.
Publicado: (2018)

Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease
por: Yari, Fatemeh Ali, et al.
Publicado: (2021)

Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
por: Karami, Sara, et al.
Publicado: (2021)

Anti-inflammatory function of apolipoprotein B-depleted plasma is impaired in non-alcoholic fatty liver disease
por: Sarmadi, Negar, et al.
Publicado: (2022)

Cardiovascular Disorders in the Context of Non-Alcoholic Fatty Liver Disease: A Literature Review
por: Karbasi-Afshar, Reza, et al.
Publicado: (2014)

Gut microbiota profile in patients with nonalcoholic fatty liver disease and presumed nonalcoholic steatohepatitis
por: Mohammadi, Zahra, et al.
Publicado: (2022)

Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy?
por: Chandrasekharan, Karthik, et al.
Publicado: (2020)

Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013)

Neuropsychiatric and Psychosocial Issues of Patients With Hepatitis C Infection: A Selective Literature Review
por: Modabbernia, Amirhossein, et al.
Publicado: (2013)

Trend of Gastrointestinal and Liver Diseases in Iran: Results of the Global Burden of Disease Study, 2010
por: Sepanlou, Sadaf Ghajarieh, et al.
Publicado: (2015)

Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study
por: Hashemi Madani, Nahid, et al.
Publicado: (2020)

Translational Aspects of Diet and Non-Alcoholic Fatty Liver Disease
por: Goossens, Nicolas, et al.
Publicado: (2017)

Metabolic Syndrome, Insulin Resistance and Fatty Liver in Obese Iranian Children
por: Saki, Forough, et al.
Publicado: (2014)

Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
por: Saadati, Saeede, et al.
Publicado: (2019)

Burden of Gastrointestinal and Liver Diseases in Iran: Estimates Based on the Global Burden of Disease, Injuries, and Risk Factors Study, 2010
por: Malekzadeh, Fatemeh, et al.
Publicado: (2015)

The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases
por: Chew, Nicholas W.S., et al.
Publicado: (2022)

Effect of Ginger Powder Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial
por: Rafie, Roya, et al.
Publicado: (2020)

Short term effects of coffee components consumption on gut microbiota in patients with non-alcoholic fatty liver and diabetes: A pilot randomized placebo-controlled, clinical trial
por: Mansour, Asieh, et al.
Publicado: (2020)

Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease
por: Pastori, Daniele, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality
por: Brouwers, Martijn C. G. J., et al.
Publicado: (2019)

Cohort profile: The Hoveyzeh Cohort Study (HCS): A prospective population-based study on non-communicable diseases in an Arab community of Southwest Iran
por: Cheraghian, Bahman, et al.
Publicado: (2020)

Burden of Gastrointestinal and Liver Diseases in Middle East and North Africa: Results of Global Burden of Diseases Study from 1990 to 2010
por: Sepanlou, Sadaf Ghajarieh, et al.
Publicado: (2015)

Editorial: The broader aspects of non-alcoholic fatty liver disease in children
por: Mandato, Claudia, et al.
Publicado: (2022)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply
por: Darvishian, Maryam, et al.
Publicado: (2021)

Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease
por: Lombardi, Rosa, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease and cardiovascular risk
por: Patil, Rashmee, et al.
Publicado: (2017)

Assessment of Cardiovascular Parameters in Obese Children and Adolescents with Non-Alcoholic Fatty Liver Disease
por: Eklioğlu, Beray Selver, et al.
Publicado: (2015)

Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease
por: Hernandez-Rodas, Maria Catalina, et al.
Publicado: (2015)

Association of Plasma Retinol Binding Protein-4 (RBP4) and Sonographic Grading of Fatty Liver in Obese Iranian Children
por: Saki, Forough, et al.
Publicado: (2012)

Assessment of common and differentially expressed proteins between diabetes mellitus and fatty liver disease: a network analysis
por: Saki, Kourosh, et al.
Publicado: (2021)

Risk Scores for Prediction of Major Cardiovascular Events in Non-Alcoholic Fatty Liver Disease: A No Man’s Land?
por: Gheorghe, Liliana, et al.
Publicado: (2023)

Comparing the risk of cardiovascular diseases and all-cause mortality in four lifestyles with a combination of high/low physical activity and healthy/unhealthy diet: a prospective cohort study
por: Kazemi, Asma, et al.
Publicado: (2022)

Dietary total antioxidant capacity is inversely associated with the odds of non-alcoholic fatty liver disease in people with type-2 diabetes
por: Salavatizadeh, Marieh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fg48jtd00nsfgr1jlpjf4j7hug